NCAPG has been shown to be relevant in a number of different cancer types, including liver cancer (26), bladder cancer (27), renal cell carcinoma (28), multiple myeloma (29), melanoma (30) and breast cancer (31). This evidence concerns the gene NCAPG and hereditary clear cell renal cell carcinoma.